Guoxing You

Guoxing You


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2013 in Critical Care
Verified
Journal Article
Open access
PDF file
GCGan Chen
Gan Chen
GYGuoxing You
Guoxing You
YWYing Wang
Ying Wang
MLMingzi Lu
Mingzi Lu
WCWeina Cheng
Weina Cheng
HZHong Zhou
Hong Zhou
Introduction: This study compared the effects of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin on oxidative stress and the inflammatory response in a rodent hemorrhagic shock model. Methods: Sodium pentobarbital-anesthetized adult male Wistar rats (200 g to 220 g) were subjected to a severe volume-controlled hemorrhage using arterial blood withdrawal (30 mL/kg to 33 mL/kg) and resuscitated with a colloid solution at the same volume as blood withdrawal (hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, or succinylated gelatin). Arterial blood gas parameters were monitored. Malondialdehyde (MDA) content and myeloperoxidase (MPO) activity in the liver, lungs, intestine, and brain were measured two hours after resuscitation. The levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 in the intestine were also measured. Results: Infusions of hydroxyethyl starch 130/0.4, but not hydroxyethyl starch 200/0.5 or succinylated gelatin, significantly reduced MDA levels and MPO activity in the liver, intestine, lungs and brain, and it also inhibited the production of TNF-α in the intestine two hours after resuscitation. However, no significant difference between hydroxyethyl starch 200/0.5 and succinylated gelatin was observed. Conclusions: Hydroxyethyl starch 130/0.4, but not hydroxyethyl starch 200/0.5 or succinylated gelatin, treatment after hemorrhagic shock ameliorated oxidative stress and the inflammatory response in this rat model. No significant differences were observed after hydroxyethyl starch 200/0.5 or succinylated gelatin administration at doses of approximately 33 mL/kg.

4 February 2015 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
GCGan Chen
Gan Chen
JZJingxiang Zhao
Jingxiang Zhao
PLPenglong Li
Penglong Li
XKXuemei Kan
Xuemei Kan
GYGuoxing You
Guoxing You
HZHong Zhou
Hong Zhou
Plasma expanders are commonly used in the management of critically ill patients, which may exhibit altered hemorheology. We evaluated the effects of various synthetic colloids and Lactated Ringer’s (LR) solution on hemorheological parameters in vitro and in a rodent hemorrhagic shock model. For the in vitro experiments, rat blood was incubated with hydroxyethyl starch (HES) 130/0.4, HES 200/0.5, succinylated gelatine (GEL), or LR at various ratios. The control consisted of blood without dilution. The hemorheological parameters were measured after a 15-min incubation. For the in vivo study, rats were subjected to a severe volume-controlled hemorrhage and were resuscitated using a colloid solution (HES 130/0.4, HES 200/0.5, or GEL) or LR. The hemorheological parameters were measured 2 h after resuscitation. The GEL significantly elevated the plasma viscosity compared to the other groups. In the in vitro study, GEL and LR accelerated the erythrocyte aggregation. There was no significant difference between HES 130/0.4, HES 200/0.5, and control groups regarding the aggregation amplitude and index. In the in vivo study, the aggregation amplitude increased significantly in the GEL group compared to the HES 130/0.4, HES 200/0.5, LR, and sham groups. There was no significant difference between the groups with respect to the elongation index in vivo. Hydroxyethyl starch did not change the erythrocyte aggregation compared to the control. GEL significantly accelerates the erythrocyte aggregation and elevates the plasma viscosity compared to hydroxyethyl starch. The in vitro hemorheological measurements most likely provide hints for the in vivo study.

1 February 2017 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
YWYing Wang
Ying Wang
WGWei Guo
Wei Guo
DGDawei Gao
Dawei Gao
GYGuoxing You
Guoxing You
BWBo Wang
Bo Wang
HZHong Zhou
Hong Zhou

22 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
ZCZongtang Chu
Zongtang Chu
WLWeidan Li
Weidan Li
GYGuoxing You
Guoxing You
YCYuzhi Chen
Yuzhi Chen
DQDong Qin
Dong Qin
HZHong Zhou
Hong Zhou
Acute altitude hypoxia represents the cause of multiple adverse consequences. Current treatments are limited by side effects. Recent studies have shown the protective effects of resveratrol (RSV), but the mechanism remains unknown. To address this, the effects of RSV on the structure and function of hemoglobin of adult (HbA) were preliminarily analyzed using surface plasmon resonance (SPR) and oxygen dissociation assays (ODA). Molecular docking was conducted to specifically analyze the binding regions between RSV and HbA. The thermal stability was characterized to further validate the authenticity and effect of binding. Changes in the oxygen supply efficiency of HbA and rat RBCs incubated with RSV were detected ex vivo. The effect of RSV on the anti-hypoxic capacity under acute hypoxic conditions in vivo was evaluated. We found that RSV binds to the heme region of HbA following a concentration gradient and affects the structural stability and rate of oxygen release of HbA. RSV enhances the oxygen supply efficiency of HbA and rat RBCs ex vivo. RSV prolongs the tolerance times of mice suffering from acute asphyxia. By enhancing the oxygen supply efficiency, it alleviates the detrimental effects of acute severe hypoxia. In conclusion, RSV binds to HbA and regulates its conformation, which enhances oxygen supply efficiency and improves adaption to acute severe hypoxia.

Verified
Journal Article
Open access
PDF file
LWLinli Wang
Linli Wang
LZLian Zhao
Lian Zhao
GYGuoxing You
Guoxing You
WLWeidan Li
Weidan Li
QZQiang Zeng
Qiang Zeng
YWYing Wang
Ying Wang
Hemocompatibility is critical for intravenous hemoglobin-based oxygen carriers (HBOCs). We evaluated the hemocompatibility of polyethylene glycol-conjugated bovine hemoglobin (PEG-bHb) to facilitate its optimization and clinical translation. PEG-bHb was synthesized and characterized. In vitro hemocompatibility was assessed by incubating blood components with PEG-bHb (2.5–40 mg/mL), evaluating erythrocyte morphology/function, coagulation, complement activation, and leu kocyte phagocytosis. In vivo assessments in Wistar rats injecting PEG-bHb (50–100 mg/kg) included erythrocyte function, coagulation, complement activation, and histopathology. PEG-bHb exhibited increased hydrodynamic diameter, unaltered zeta potential, elevated colloidal osmotic pressure (COP) and viscosity, alongside a decreased P50 versus bovine hemoglobin (bHb). In vitro, PEG-bHb preserved erythrocyte morphology without inducing eryptosis, and oxygen supply efficiency was unaffected. Moreover, it slightly disrupted the activated partial thromboplastin time (APTT), the thrombin time (TT), and the platelet adhesion, while platelet activation and thromboelastography (TEG) remained unchanged. PEG-bHb did not activate complement and only mildly enhanced phagocytosis at 2.5 mg/mL. In vivo, PEG-bHb did not affect eryptosis, oxygen supply efficiency, coagulation, complement activation, and no inflammatory infiltration was observed. PEG-bHb maintains erythrocyte morphology and function, slightly perturb coagulation without compromising immunocompatibility, and demonstrated excellent hemocompatibility.

1 March 2008
Verified
Journal Article
Closed access
LZLian Zhao
Lian Zhao
BWBo Wang
Bo Wang
GYGuoxing You
Guoxing You
LSLi-Yan Su
Li-Yan Su
LYLei Yu
Lei Yu
HZHong Zhou
Hong Zhou